Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs

Adlarity has 7 Advantages over Donepezil Tablets

October 22, 2023 No Comments

FDA-approved ADLARITY is the once-weekly donepezil patch. See how it compares to donepezil / Aricept / Ebixa tablets for Alzheimer’s.

ARIA in Lacanemab, Donanemab and Aduhelm

September 8, 2023 No Comments

A neuroradiologist at the Mayo Clinic in Jacksonville, FL warns that increased use of monoclonal antibody treatment for Alzheimer’s has also led to the discovery of amyloid-related imaging abnormalities — ARIA. Find out more.

laboratory, test tubes, healthcare worker

A Timeline of Alzheimer’s Drug Development

September 7, 2023 No Comments

The first drugs for Alzheimer’s disease emerged in the 1990s, but since then there has been a wave of clinical trial failures, major companies pulling resources from neuroscience R&D, and progress.

woman wearing yellow and pink floral dress wahing carrots

Prescribing Lecanemab in Real Life

July 28, 2023 1 Comment

Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.

Lilly’s Donanemab: The 3rd New Alzheimer’s Drug

July 21, 2023 No Comments

Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.

New Alzheimer’s Drug Lecanemab: High price tag, Moderate warnings

July 14, 2023 No Comments

The FDA has approved generic lecanemab (brand name Leqembi^®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.

Leqembi Medication for Alzheimer's (Generic: Lecanemab)

Alzheimer’s Drug Leqembi Gets Full FDA and MEDICARE Approval

July 7, 2023 No Comments

First drug to modestly slow Alzheimer’s cognitive decline, based on 1,800 patients.

FDA Unanimously Votes Leqembi Benefits Alzheimer’s

June 11, 2023 1 Comment

The FDA Advisory Committee’s endorsement of Leqembi paves way for traditional approval, ushers in a new era for Alzheimer’s

FDA Votes 9-1 to Advance Rexulti for Alzheimer’s

May 15, 2023 No Comments

The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.

woman in white coat holding black dslr camera

Next Alzheimer’s Drug? Donamebab Significantly Slows Cognitive Decline

May 3, 2023 No Comments

Eli Lilly Company’s TRAILBLAZER-ALZ 2 Phase 3 study shows that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease. Learn more.

Bragg's Pineapple Turmeric Apple Cider Vinegar Blend

Sipping Smarter: Delicious Vinegar-Turmeric Drink Fortifies Against Alzheimer’s

July 17, 2025

A new pineapple turmeric apple cider vinegar blend from Bragg is turning heads—not just for its flavor, but for its potential brain-boosting benefits. Could this tangy tonic play a role in Alzheimer’s prevention?

You Are Not Alone: Dealing with Lewy Body Dementia

July 17, 2025

All a caregiver for Lewy Body Dementia needs to know, from symptoms to diagnosis to care for their loved one and themselves, for the entire caregiving journey. Part memoir and part help book.

Opioids & Dementia: New Study Finds Strong Link

July 16, 2025

Does pain relief risk cognitive cost? A major new study of almost 200,000 people says yes—and the price may be higher than we thought.

Most Popular Stories

kid, coffee, cup, breakfast, tiny, kids, small, coffee, coffee, coffee, coffee, coffee, kids

Big Cup, Little Man: Picking Up the Earliest Signs of Alzheimer’s

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

85 with Dementia? Good Chance It’s HS-AGING, Not Alzheimer’s

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?